(1.17%) 5 123.28 points
(1.16%) 38 667 points
(1.96%) 16 151 points
(-0.54%) $78.52
(5.06%) $2.14
(-0.36%) $2 301.20
(-0.85%) $26.60
(-0.07%) $961.95
(-0.42%) $0.928
(-1.34%) $10.84
(-0.12%) $0.797
(0.40%) $91.49
Live Chart Being Loaded With Signals
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe...
Stats | |
---|---|
Dagens volum | 11 349.00 |
Gjennomsnittsvolum | 18 094.00 |
Markedsverdi | 13.41M |
EPS | $0 ( 2024-03-28 ) |
Neste inntjeningsdato | ( $-0.600 ) 2024-07-04 |
Last Dividend | $0.220 ( 2015-06-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0900 |
ATR14 | $0.0300 (1.69%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-02-13 | Robert R Mccormick Tribune Foundation | Sell | 65 200 | Common Stock |
2004-02-17 | Robert R Mccormick Tribune Foundation | Sell | 92 000 | Common Stock |
2004-02-18 | Robert R Mccormick Tribune Foundation | Sell | 17 800 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 3 transactions |
Buy: 0 | Sell: 175 000 |
Trinity Biotech PLC Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
GRCL | 0.905 |
NETE | 0.9 |
JOAN | 0.895 |
RXT | 0.886 |
CUTR | 0.885 |
VNDA | 0.88 |
KPTI | 0.88 |
UDMY | 0.88 |
PTPI | 0.878 |
POTX | 0.878 |
10 Mest negative korrelasjoner | |
---|---|
SVAC | -0.899 |
AUPH | -0.891 |
USCR | -0.88 |
RARE | -0.879 |
PAIC | -0.877 |
MLVF | -0.866 |
EZGO | -0.865 |
SUMR | -0.863 |
AMYT | -0.861 |
IIN | -0.859 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Trinity Biotech PLC Økonomi
Annual | 2023 |
Omsetning: | $56.83M |
Bruttogevinst: | $18.50M (32.56 %) |
EPS: | $-15.69 |
FY | 2023 |
Omsetning: | $56.83M |
Bruttogevinst: | $18.50M (32.56 %) |
EPS: | $-15.69 |
FY | 2022 |
Omsetning: | $74.78M |
Bruttogevinst: | $22.05M (29.48 %) |
EPS: | $-6.08 |
FY | 2021 |
Omsetning: | $92.97M |
Bruttogevinst: | $38.08M (40.96 %) |
EPS: | $0.0400 |
Financial Reports:
No articles found.
Trinity Biotech PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.400 | 2011-06-07 |
Last Dividend | $0.220 | 2015-06-05 |
Next Dividend | $0 | N/A |
Payout Date | 2015-07-01 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | $1.190 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.55 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2011 | $0.400 | 4.67% |
2012 | $0.150 | 1.49% |
2013 | $0.200 | 1.36% |
2014 | $0.220 | 0.88% |
2015 | $0.220 | 1.21% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.431 | 1.500 | -8.63 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.412 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 1.650 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.60 | 0.800 | 2.02 | 1.613 | [1 - 3] |
quickRatioTTM | 1.271 | 0.800 | 7.23 | 5.78 | [0.8 - 2.5] |
cashRatioTTM | 0.245 | 1.500 | 9.75 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.923 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -2.41 | 1.000 | -2.00 | -2.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -8.33 | 2.00 | -2.78 | -5.55 | [0 - 30] |
freeCashFlowPerShareTTM | -10.09 | 2.00 | -5.05 | -10.00 | [0 - 20] |
debtEquityRatioTTM | -2.29 | -1.500 | -9.16 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.334 | 1.000 | 7.76 | 7.76 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.471 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.233 | 1.000 | -2.40 | -2.40 | [0.2 - 2] |
assetTurnoverTTM | 0.956 | 0.800 | 6.96 | 5.57 | [0.5 - 2] |
Total Score | -1.023 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.105 | 1.000 | -0.112 | 0 | [1 - 100] |
returnOnEquityTTM | 1.650 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -10.09 | 2.00 | -3.36 | -10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -8.33 | 2.00 | -2.78 | -5.55 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00136 | 1.500 | -3.32 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.225 | 1.000 | -8.12 | 0 | [0.1 - 0.5] |
Total Score | -1.549 |
Trinity Biotech PLC
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.